A new FDA-approved drug takes aim at a deadly form of tuberculosis

The antibiotic, paired with two others, works against highly drug-resistant TB

a photo of Mycobacterium tuberculosis

DEADLY RESISTANCE  Tuberculosis is caused by Mycobacterium tuberculosis (shown). A drug newly approved by the U.S. Food and Drug Administration could help combat a highly drug-resistant form of the disease.

NIAID

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Humans

From the Nature Index

Paid Content